Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Clinical trial NCT03462446 · COMPLETED

Trial details

NCT number: NCT03462446
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2015-06-01
Primary completion: 2016-05-01
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.